title: Carbon monoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329-337).
authors.forename: A
authors.initials: A
authors.lastname: Loboda
authors.forename: A
authors.initials: A
authors.lastname: Jozkowicz
authors.affiliation: Prof. Jozef Dulak, PhD, DSc, Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland, Tel.: +48 12 664 63 75, Fax: +48 12 664 69 18, E-mail: jozef.dulak@uj.edu.pl.
authors.forename: J
authors.initials: J
authors.lastname: Dulak
mesh_terms: D000818:Animals; D002248:Carbon Monoxide / Q000737:chemistry*; D006801:Humans; D009389:Neovascularization, Pathologic; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*
chemical_list: D002248:Carbon Monoxide; D040301:Vascular Endothelial Growth Factor Receptor-2